SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017293
Filing Date
2019-05-08
Accepted
2019-05-08 16:55:24
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2019 10-Q snss-10q_20190331.htm 10-Q 1092502
2 EX-31.1 snss-ex311_8.htm EX-31.1 16672
3 EX-31.2 snss-ex312_7.htm EX-31.2 16846
4 EX-32.1 snss-ex321_6.htm EX-32.1 9344
5 GRAPHIC gtv4rvs0hxiq000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-19-017293.txt   3549846

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20190331.xml EX-101.INS 529847
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20190331.xsd EX-101.SCH 39593
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20190331_cal.xml EX-101.CAL 38940
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20190331_def.xml EX-101.DEF 126633
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20190331_lab.xml EX-101.LAB 290581
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20190331_pre.xml EX-101.PRE 209608
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 19807423
SIC: 2834 Pharmaceutical Preparations